# Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease

> **NCT04012411** · NA · RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 135 (estimated)

## Conditions studied

- Huntington Disease

## Interventions

- **PROCEDURE:** Brain MRI
- **PROCEDURE:** Lumbar Punction
- **GENETIC:** Blood sample
- **OTHER:** Cognitive evaluation

## Key facts

- **NCT ID:** NCT04012411
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-03
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04012411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04012411, "Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT04012411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*